DiviDrip · RXRX

RXRX — Recursion Pharmaceuticals, Inc.

RXRX is Recursion Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.63. Market cap: $1.95B. Capital Quality Rank: 28/100 — Capital destroyer.

Stock snapshot

Price$3.63
Market cap$1.95B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)28 / 100 · Capital destroyer
ROIC (TTM)-128.9%
Revenue CAGR (3y)23.3%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About RXRX

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Listed2021Employees600HQSalt Lake City, UTSectorHealthcareWebsiterecursion.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RXRX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RXRX's current stock price?

RXRX (Recursion Pharmaceuticals, Inc.) is currently trading at $3.63.

Does RXRX pay a dividend?

RXRX (Recursion Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is RXRX's Capital Quality Rank?

RXRX has a Capital Quality Rank of 28/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RXRX in DiviDrip

Add RXRX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow